Akèy › Maladi Alzheimer › North Carolina
Etid klinik pou Maladi Alzheimer nan North Carolina
21 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- AMC Research, LLC, Matthews
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- West Clinical Research, Morehead City
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Triad Clinical Trials - 515 College Rd, Greensboro
- AMC Research, LLC - Flourish - PPDS, Matthews
- West Clinical Research, Morehead City
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Triad Clinical Trials, Greensboro
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- West Clinical Research, Morehead City
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745ADRC Clinical Cohort (Alzheimer's Disease)
- Duke University, Durham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 25 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06703541Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- UNC Health REX Hospital, Raleigh
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- AMC Research, LLC ( Site 1006), Matthews
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Duke University, Durham
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- AMC Research, LLC, Matthews
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Flourish Research, Matthews
Ap rekriteFaz 1/2
Laj 35 a 85 · Tout sèks · Mizajou Jul 10, 2026 · NCT05462106A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Monroe Biomedical Research, Monroe
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- UNC Hosp Invest Drug Serv Pharm, Chapel Hill
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516Olfactory Biopsies
- Duke University Health Center, Durham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT07021040A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Duke Early Phase Research Unit, Durham
Ap rekriteFaz 1Volontè an sante akeyi
Laj 45 a 85 · Tout sèks · Mizajou Jun 4, 2026 · NCT06657768Late Onset Alzheimer's Disease
- North Carolina State University, Raleigh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05010603Connect-Home: Alzheimer's Disease and Related Dementias
- University of North Carolina at Chapel Hill, Chapel Hill
Ap rekrite
Laj 19 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT06840587Wake Forest Alzheimer's Disease Clinical Core
- Wake Forest Baptist Health, Winston-Salem
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT03140865Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT03233646Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Matthews
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Feb 2, 2026 · NCT07105709Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.